$1.17
0.065.41%
Last update: Nov 6, 9:49 AM
Aardvark Therapeutics Inc
AARDNASDAQ
The average analyst price target for Aardvark Therapeutics is $10, 754.7% above the current price. Of 11 analysts, 6 rate it Buy, 4 Hold and 1 Sell. Targets range from $2 to $25. The latest change came on Oct 27, 2026, when Jones Trading lowered its price target on Aardvark Therapeutics from $19 to $10 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
